Skye Biosience Inc. (OTCMKTS: SKYE) has announced that its SBI-100 ophthalmic nanoemulsion treatment showed a trend of retaining enhanced retinal ganglion cells function in eyes in...
Punit Dhillon, Skye Bioscience Inc (OTCMKTS: SKYE) Chief Executive Officer recently wrote a letter to the company’s shareholders detailing the company’s current progress and business outlook...
Skye Bioscience Inc (OTCMKTS: SKYE) is on an appointment spree. The group has hired new professionals for various positions. Here’s a list of the professionals who...
Skye Bioscience Inc (OTCMKTS: SKYE) has announced that the University of Mississippi, one of its partners, will release preclinical data on October 17- October 20, 2021,...
Skye Biosciences Inc. (OTCMKTS: SKYE) has announced the completion of genotoxicity THCVHS studies necessary to commence its expected Phase 1 clinical trial in Australia. THCVHS for...
It seems the recent approvals of cannabinoid-based therapies are still not enough. According to Skye Bioscience Inc. (OTCMKTS: SKYE), they have just scratched the surface of...
